Published in Health Insurance Week, May 20th, 2007
It is anticipated that treatments under HMSA's commercial evaluation will commence before the end of Hythiam's second fiscal quarter ending June 30, 2007. Up to 50 patients will receive the PROMETA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.